Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy

Multi-target Tyrosine Kinase Inhibitors (MTKIs) have drawn substantial attention in tumor therapy. MTKIs could inhibit tumor cell proliferation and induce apoptosis by blocking the activity of tyrosine kinase. However, the toxicity and drug resistance of MTKIs severely restrict their further clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenjing, Ye, Chunping, Qing, Xin, Liu, Shengli, Lv, Xinyi, Wang, Wenjun, Dong, Xiaochen, Zhang, Yewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307458/
https://www.ncbi.nlm.nih.gov/pubmed/35880099
http://dx.doi.org/10.1016/j.mtbio.2022.100358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307458/
https://www.ncbi.nlm.nih.gov/pubmed/35880099
http://dx.doi.org/10.1016/j.mtbio.2022.100358

Ejemplares similares